Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Axel Kleespies

Showing results (1-10 of 57) with videos related to

Pageof 6
Sort By:
Journal of Surgical Oncology|April 15, 2006
Re: the risk of developing metastatic disease in colorectal cancer is related to CD105-positive vessel count, by Romani AA, Borghetti AF, Del Rio P, et alAxel Kleespies
MMW Fortschritte Der Medizin|June 1, 2010
[Advanced sigmoid carcinoma: how to manage this colostomy?]Philipe N Khalil, Jana Eisenlohr, Axel Kleespies
Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy|April 20, 2006
Tyrosine kinase inhibitors and gemcitabine: new treatment options in pancreatic cancer?Axel Kleespies, Karl-Walter Jauch, Christiane J Bruns
Onkologie|May 4, 2005
Clinical significance of VEGF-A, -C and -D expression in esophageal malignanciesAxel Kleespies, Christiane J Bruns, Karl-Walter Jauch
Nuklearmedizin. Nuclear Medicine|August 1, 2022
Determinants and clinical significance of negative scintigraphic findings in primary hyperparathyroidism: a retrospective observational studyMichael Neuberger, Jan Axl Dropmann, Axel Kleespies, et al.
MMW Fortschritte Der Medizin|November 9, 2010
[Frequently suspected, often suspected and seldom found. Diagnosis at a glance in laparotomy]Philipe N Khalil, Axel Kleespies, K Angele, et al.
Journal of Surgical Oncology|July 30, 2004
Vascular endothelial growth factor in esophageal cancerAxel Kleespies, Markus Guba, Karl-Walter Jauch, et al.
International Journal of Colorectal Disease|February 18, 2009
Perioperative fluid retention and clinical outcome in elective, high-risk colorectal surgeryAxel Kleespies, Manfred Thiel, Karl-Walter Jauch, et al.
International Journal of Colorectal Disease|March 5, 2004
Vascular endothelial growth factor in colorectal cancerMarkus Guba, Hendrik Seeliger, Axel Kleespies, et al.
Cancer Metastasis Reviews|August 24, 2007
Role of mTOR in solid tumor systems: a therapeutical target against primary tumor growth, metastases, and angiogenesisHendrik Seeliger, Markus Guba, Axel Kleespies, et al.
Pageof 6

Showing results (1-10 of 57) with videos related to

Sort By:
Pageof 6
Journal of Surgical Oncology|April 15, 2006
Re: the risk of developing metastatic disease in colorectal cancer is related to CD105-positive vessel count, by Romani AA, Borghetti AF, Del Rio P, et alAxel Kleespies
MMW Fortschritte Der Medizin|June 1, 2010
[Advanced sigmoid carcinoma: how to manage this colostomy?]Philipe N Khalil, Jana Eisenlohr, Axel Kleespies
Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy|April 20, 2006
Tyrosine kinase inhibitors and gemcitabine: new treatment options in pancreatic cancer?Axel Kleespies, Karl-Walter Jauch, Christiane J Bruns
Onkologie|May 4, 2005
Clinical significance of VEGF-A, -C and -D expression in esophageal malignanciesAxel Kleespies, Christiane J Bruns, Karl-Walter Jauch
Nuklearmedizin. Nuclear Medicine|August 1, 2022
Determinants and clinical significance of negative scintigraphic findings in primary hyperparathyroidism: a retrospective observational studyMichael Neuberger, Jan Axl Dropmann, Axel Kleespies, et al.
MMW Fortschritte Der Medizin|November 9, 2010
[Frequently suspected, often suspected and seldom found. Diagnosis at a glance in laparotomy]Philipe N Khalil, Axel Kleespies, K Angele, et al.
Journal of Surgical Oncology|July 30, 2004
Vascular endothelial growth factor in esophageal cancerAxel Kleespies, Markus Guba, Karl-Walter Jauch, et al.
International Journal of Colorectal Disease|February 18, 2009
Perioperative fluid retention and clinical outcome in elective, high-risk colorectal surgeryAxel Kleespies, Manfred Thiel, Karl-Walter Jauch, et al.
International Journal of Colorectal Disease|March 5, 2004
Vascular endothelial growth factor in colorectal cancerMarkus Guba, Hendrik Seeliger, Axel Kleespies, et al.
Cancer Metastasis Reviews|August 24, 2007
Role of mTOR in solid tumor systems: a therapeutical target against primary tumor growth, metastases, and angiogenesisHendrik Seeliger, Markus Guba, Axel Kleespies, et al.
Pageof 6